Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3422)
All Articles published online
|
Dec 14, 2007 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Amarapurkar DN. Telbivudine: A new treatment for chronic hepatitis B. World J Gastroenterol 2007; 13(46): 6150-6155 [PMID: 18069753 DOI: 10.3748/wjg.v13.i46.6150] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i46/6150.htm |
| Number | Citing Articles |
| 1 |
J. Liu, T. Chen, Y. Zhao. Telbivudine therapy for gravidas with chronic hepatitis B infection and patients at risk of renal impairment. Journal of Viral Hepatitis 2017; 24(S1): 6 doi: 10.1111/jvh.12787
|
| 2 |
Weiping Lyu, Haoming Qin, Qi Li, Dehua Lu, Cheng Shi, Kangchen Zhao, Shengran Zhang, Ruohan Yu, Huiying Zhang, Xiaonan Zhou, Sitian Xia, Liangren Zhang, Xiaoqian Wang, Xiaowei Chi, Zhenming Liu. Novel mechanistic insights – A brand new Era for anti-HBV drugs. European Journal of Medicinal Chemistry 2024; 279: 116854 doi: 10.1016/j.ejmech.2024.116854
|
| 3 |
Erik O. Soley, Zachary J. Devereaux, L.A. Hamlow, G. Berden, J. Oomens, M.T. Rodgers. IRMPD action spectroscopy, ER-CID experiments, and theoretical approaches investigate intrinsic L-thymidine properties compared to D-thymidine: Findings support robust methodology. International Journal of Mass Spectrometry 2019; 441: 32 doi: 10.1016/j.ijms.2019.04.003
|
| 4 |
Akram Hegazy, Sara H. Mahmoud, Ahmed Magdy Khalil, Luis Martinez-Sobrido, Ahmed Mostafa. Microbial Genomics: Clinical, Pharmaceutical, and Industrial Applications. 2024; : 219 doi: 10.1016/B978-0-443-18866-4.00009-2
|
| 5 |
Li-fen Han, Jian-ming Zheng, Li-qing Zheng, Hai-bing Gao, Li-xia Chen, Qing-ling Xu, Yi-hong Chai, Xin Zhang, Chen Pan, Lv-feng Yao. Telbivudine can safely reduce mother-to-child transmission in chronic hepatitis B women after 12 weeks of gestation. BMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-4250-6
|
| 6 |
Vignesh Ravi. QSPR analysis of drugs used for treatment of hepatitis via reduced reverse degree-based topological descriptors. Physica Scripta 2024; 99(10): 105236 doi: 10.1088/1402-4896/ad729d
|
| 7 |
Sarkar M.A. Kawsar, Nasrin S. Munia, Supriyo Saha, Yasuhiro Ozeki. In Silico Pharmacokinetics, Molecular Docking and Molecular Dynamics
Simulation Studies of Nucleoside Analogs for Drug Discovery- A Mini
Review. Mini-Reviews in Medicinal Chemistry 2024; 24(11): 1070 doi: 10.2174/0113895575258033231024073521
|
| 8 |
Annapoorna Vadlamani, K. Ravindhranath, B. Sreenivasa Rao. Detection and Quantification of Two Potential Genotoxic Impurities in Telbivudine Active
Pharmaceutical Ingredient by Targeted Ultra Performance LC-MS/MS Analysis. Asian Journal of Chemistry 2022; 34(12): 3383 doi: 10.14233/ajchem.2022.26905
|
| 9 |
Jinxin Zheng, Minggui Deng, Xiaoliang Qiu, Zhong Chen, Duoyun Li, Xiangbin Deng, Qiwen Deng, Zhijian Yu. Rhabdomyolysis, lactic acidosis, and multiple organ failure during telbivudine treatment for hepatitis B: a case report and review of the literature. Journal of Medical Case Reports 2017; 11(1) doi: 10.1186/s13256-017-1498-6
|
| 10 |
Florina-Daniela Cojocaru, Doru Botezat, Ioannis Gardikiotis, Cristina-Mariana Uritu, Gianina Dodi, Laura Trandafir, Ciprian Rezus, Elena Rezus, Bogdan-Ionel Tamba, Cosmin-Teodor Mihai. Nanomaterials Designed for Antiviral Drug Delivery Transport across Biological Barriers. Pharmaceutics 2020; 12(2): 171 doi: 10.3390/pharmaceutics12020171
|
| 11 |
Yarden Ariav, James H Ch’ng, Heather R. Christofk, Noga Ron-Harel, Ayelet Erez. Targeting nucleotide metabolism as the nexus of viral infections, cancer, and the immune response. Science Advances 2021; 7(21) doi: 10.1126/sciadv.abg6165
|
| 12 |
Jia‐Horng Kao, Tarik Asselah, Xiao‐Guang Dou, Kamal Hamed. Telbivudine therapy for chronic hepatitis B: A journey to identify super‐responders and to optimize treatment using the roadmap model. Journal of Gastroenterology and Hepatology 2017; 32(1): 73 doi: 10.1111/jgh.13512
|
| 13 |
Reena Singh, Seema Gupta, Pradeep Kumar. The Role of Nanotechnology in Antiviral Regime: An Overview. Nano LIFE 2022; 12(01) doi: 10.1142/S1793984421300119
|
| 14 |
Milena Georgieva, Charilaos Xenodochidis, Natalia Krasteva. Old age as a risk factor for liver diseases: Modern therapeutic approaches. Experimental Gerontology 2023; 184: 112334 doi: 10.1016/j.exger.2023.112334
|
| 15 |
Wattana Leowattana, Tawithep Leowattana. Chronic hepatitis B: New potential therapeutic drugs target. World Journal of Virology 2022; 11(1): 57-72 doi: 10.5501/wjv.v11.i1.57
|